Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,455 | -3,579 | -14,400 | -10,466 | -7,160 |
| Depreciation Amortization | 452 | 263 | 1,003 | 618 | 449 |
| Accounts receivable | 6 | N/A | 40 | 18 | 4 |
| Accounts payable and accrued liabilities | 68 | -194 | -89 | -265 | -217 |
| Other Working Capital | 1,142 | -124 | 605 | 1,478 | 1,417 |
| Other Operating Activity | 3,024 | 589 | 2,473 | 1,103 | 982 |
| Operating Cash Flow | $-4,763 | $-3,045 | $-10,368 | $-7,514 | $-4,525 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,096 | -1,151 | N/A | N/A | -7,590 |
| PPE Investments | 219 | N/A | -22 | -13 | -9 |
| Purchase Of Investment | N/A | N/A | -18,613 | -17,169 | N/A |
| Sale Of Investment | 1,613 | 2,039 | 10,044 | 8,497 | 8,497 |
| Purchase Sale Intangibles | -365 | -365 | -573 | -297 | -297 |
| Other Investing Activity | -365 | -365 | -573 | -297 | -297 |
| Investing Cash Flow | $-629 | $523 | $-9,164 | $-8,982 | $601 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -355 | N/A | N/A |
| Debt Repayment | -4,854 | -93 | -4,330 | -4,544 | -4,459 |
| Common Stock Issued | 12,887 | 12,887 | 61,248 | 58,066 | 40,821 |
| Financing Cash Flow | $8,033 | $12,794 | $56,563 | $53,522 | $36,362 |
| Beginning Cash Position | 38,501 | 38,501 | 1,470 | 1,470 | 1,470 |
| End Cash Position | 41,142 | 48,773 | 38,501 | 38,496 | 33,908 |
| Net Cash Flow | $2,641 | $10,272 | $37,031 | $37,026 | $32,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,763 | -3,045 | -10,368 | -7,514 | -4,525 |
| Capital Expenditure | -26 | N/A | -22 | -13 | -9 |
| Free Cash Flow | -4,789 | -3,045 | -10,390 | -7,527 | -4,534 |